2-(2-(Difluoromethyl)-6-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

ETHYL 2-(2-CHLOROPHENYL)-2-CYANOACETATE, 95.0%, 1g

5-(4-Bromophenyl)isoxazole-3-carbaldehyde, 96%, 250mg

Fmoc-2-Abz-OH, 100g

1-Phenyl-1H-pyrazole-5-carbaldehyde, 95.0%, 2.5g

(S)-4-(tert-Butyl)-2-(5,6,7,8-tetrahydroquinolin-2-yl)-4,5-dihydrooxazole, 97%, 100mg

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-(4-methyltrityl)-L-lysine>98.0%(HPLC)(N)5g

Ethyl 6-cyanonicotinate, 95.0%, 1g

(R)-N-(1-(5-(Trifluoromethyl)pyridin-2-yl)ethyl)cyclopropanamine, 250mg

3-(ethoxycarbonyl)-1-(2-methyl-4-nitrophenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

4-(3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide, 95.0%, 1g

N-cyclohexyl-N-methylalanine, 95.0%, 250mg

5-Bromo-2-chloro-3-methylpyrazine, 97%, 1g